Results 161 to 170 of about 42,053 (270)

Modifiable Risk Factors in Atrial Fibrillation: Clinical Implications and Pathophysiological Insights

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 2, March 2026.
Modifiable cardiometabolic and lifestyle factors converge on shared atrial mechanisms, including fibrosis, autonomic imbalance, and electrical remodeling, to promote AF initiation and recurrence. Targeting these upstream drivers through structured risk‐factor management enhances rhythm‐control durability and improves long‐term clinical outcomes ...
Chamath Jagoda
wiley   +1 more source

Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic Drugs. [PDF]

open access: yesPharmaceuticals (Basel)
Ellermann C   +7 more
europepmc   +1 more source

Temporal Characteristics and Management of Prolonged Sinus Pause Following Atrial Fibrillation Termination After Catheter Ablation—A Preliminary Study

open access: yesAnnals of Noninvasive Electrocardiology, Volume 31, Issue 2, March 2026.
Twelve of the 1330 patients who underwent AF catheter ablation showed PSP ≥ 3 s after AF termination post ablation. The temporal characteristics of PSP were described. Nine of the 12 patients had no need for permanent pacing. We concluded that a ‘watch‐and‐wait’ strategy could be adopted in these patients.
Yi Guo   +12 more
wiley   +1 more source

Identifying Drugs Associated With Parkinson's Disease Risk Using Machine Learning

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 138, Issue 3, March 2026.
ABSTRACT Machine learning (ML)–based methods have been proposed as a potential approach for identifying candidate drugs to be repurposed as disease‐modifying treatments for Parkinson's disease (PD). We applied an ML‐based signal detection method to identify drugs associated with PD and evaluated the method's generalizability.
Eeva Pylkkö   +8 more
wiley   +1 more source

Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation. [PDF]

open access: yesCochrane Database Syst Rev, 2023
Bray JJH   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy